Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Inudap M 5/500 Tablet ER

Prescription Icon
Prescription Required

Marketer

Inuen Healthcare Pvt Ltd

Salt Composition

Dapagliflozin (5mg) + Metformin (500mg)

Overview Inudap M 5/500 Tablet ER

Inudap M 5/500 Extended-Release tablets combine two medications to manage type 2 diabetes. This dual-action formulation effectively lowers elevated blood glucose, mitigating the risk of serious diabetic complications and contributing to heart health. Inudap M 5/500 ER can be taken with food, consistently at the same time daily for optimal adherence. Dosage is determined by your physician, and discontinuation requires their consultation; abrupt cessation may elevate blood sugar, potentially causing kidney damage or vision impairment. This medication forms part of a comprehensive diabetes management plan encompassing dietary adjustments, regular physical activity, and weight management as directed by your doctor. Commonly reported side effects include upper respiratory symptoms (sore throat, nasal congestion, rhinorrhea), headache, gastrointestinal upset (nausea, vomiting, diarrhea), and dehydration, mitigated by adequate hydration. Genital fungal infections are a possibility; diligent hygiene is recommended. Prior to commencing treatment, disclose any kidney or liver disease, urinary tract infections, diuretic use, pregnancy, or breastfeeding to your doctor. Limit alcohol consumption, as it may exacerbate side effects. Regular blood glucose monitoring is crucial throughout therapy.

Primary Ingredients of Inudap M 5/500 Tablet ER

The provided text is "undefined," therefore no rewriting is possible.

Uses of Inudap M 5/500 Tablet ER

Managing type 2 diabetes

Major Benefits of Inudap M 5/500 Tablet ER:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Inudap M 5/500 Tablet ER with a meal.

Common Side effects of Inudap M 5/500 Tablet ER:

  • Nausea
  • Vomiting
  • Diarrhea
  • Genital fungal infection
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Urinary tract infection
  • Polyuria
  • Flatulence
  • Skin rash
  • Taste change
  • Difficulty in urination
  • Hypoglycemia (low blood glucose level)
  • Tremors
  • Dizziness
  • Back pain
  • Increased hematocrit
  • Decreased creatinine clearance
  • Dyslipidemia

How to use Inudap M 5/500 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Inudap M 5/500 Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.

How Inudap M 5/500 Tablet ER works:

Inudap M 5/500 Extended-Release tablets combine dapagliflozin and metformin to effectively manage blood glucose levels. Dapagliflozin facilitates glucose excretion via the kidneys, while metformin reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual-action approach optimizes blood sugar regulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Avoid alcohol consumption while taking Inudap M 5/500 Tablet ER.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Inudap M 5/500 tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescription. Seek medical advice before use.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Inudap M 5/500 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Inudap M 5/500 Tablet ER. Dosage modification of Inudap M 5/500 Tablet ER might be necessary. A physician's advice is recommended.

LiverLiverCAUTION

Patients with liver impairment should exercise caution when using Inudap M 5/500 Extended-Release tablets. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Inudap M 5/500 Tablet ER :

Should you forget a dose of Inudap M 5/500 Tablet ER, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Inudap M 5/500 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
Inudap M 5/500 Tablet ER
73
MRP 85
14% off